Browsing: Pediatrics

A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).

Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.

A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.

The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.

Living in U.S. counties with higher concentrations of poverty was associated with increased risk of firearm-related deaths among children and young adults, according to a recent study.

On November 5, students in the Master of Prosthetics & Orthotics (MPO) program through Northwestern’s Prosthetics-Orthotics Center constructed more than 50 braces for teddy bears gifted to pediatric patients at Ann & Robert H. Lurie Children’s Hospital.

Ann & Robert H. Lurie Children’s Hospital of Chicago has recruited an internationally recognized surgeon-scientist, Thomas H. Inge, MD, PhD, as the hospital’s next surgeon-in-chief.

Tisagenlecleucel, a chimeric antigen receptor (CAR) T-cell immunotherapy, demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia, according to recent findings.

Northwestern Medicine scientists have characterized several variants of the gene GRIK2 that cause nonsyndromic neurodevelopmental disorder.

Children born to women with epilepsy who took anti-seizure medications during pregnancy versus children born to women without epilepsy did not differ in terms of cognitive outcomes and overall neurodevelopment, according to findings published in JAMA Neurology.